Diane M Citron Selected Research

Therapeutics

1/2020	Bezlotoxumab for the Prevention of Recurrent Clostridioides difficile Infection: 12-Month Observational Data From the Randomized Phase III Trial, MODIFY II.
12/2017	In Vitro Activities of Pexiganan and 10 Comparator Antimicrobials against 502 Anaerobic Isolates Recovered from Skin and Skin Structure Infections.
8/2016	Ridinilazole: a novel therapy for Clostridium difficile infection.
8/2014	Comparative in vitro activities of dalbavancin and seven comparator agents against 41 Staphylococcus species cultured from osteomyelitis infections and 18 VISA and hVISA strains.
12/2011	Clinical efficacy and correlation of clinical outcomes with in vitro susceptibility for anaerobic bacteria in patients with complicated intra-abdominal infections treated with moxifloxacin.
8/2011	Multi-drug resistant Bacteroides fragilis recovered from blood and severe leg wounds caused by an improvised explosive device (IED) in Afghanistan.
4/2008	Virulence characteristics of community-associated Staphylococcus aureus and in vitro activities of moxifloxacin alone and in combination against community-associated and healthcare-associated meticillin-resistant and -susceptible S. aureus.
11/2005	Ertapenem versus piperacillin/tazobactam for diabetic foot infections (SIDESTEP): prospective, randomised, controlled, double-blinded, multicentre trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Diane M Citron Research Topics

Disease

30	Infections 11/2020 - 03/2002
9	Wounds and Injuries (Trauma) 01/2018 - 08/2004
8	Clostridium Infections 11/2021 - 11/2011
7	Diabetic Foot 02/2017 - 11/2005
6	Intraabdominal Infections 08/2018 - 01/2006
6	Bites and Stings (Sting) 01/2018 - 03/2002
4	Soft Tissue Infections 02/2017 - 09/2002
4	Sinusitis 01/2007 - 02/2002
2	Cross Infection (Nosocomial Infection) 04/2017 - 12/2009
2	Diarrhea 04/2016 - 12/2009
2	Reinfection 09/2012 - 08/2012
2	Coinfection 07/2011 - 04/2009
2	Pelvic Infection 05/2011 - 11/2002
2	Respiratory Tract Infections (Respiratory Tract Infection) 01/2007 - 04/2003
2	Human Bites (Bite, Human) 09/2002 - 03/2002
1	Bacteremia 02/2017
1	Osteomyelitis 08/2014
1	Weight Gain 09/2012
1	Cystic Fibrosis (Mucoviscidosis) 02/2010
1	Shock 06/2009
1	Aspiration Pneumonia 01/2007
1	Peritonitis 08/2006
1	Cellulitis 03/2005
1	Bacterial Vaginosis 08/2002

Drug/Important Bio-Agent (IBA)

10	Anti-Bacterial Agents (Antibiotics)IBA 08/2018 - 03/2002
8	Ertapenem (Invanz)FDA Link 04/2009 - 04/2002
6	Vancomycin FDA LinkGeneric 08/2018 - 04/2010
6	Anti-Infective Agents (Microbicides)IBA 01/2017 - 02/2002
5	Methicillin (Metin)FDA Link 04/2010 - 08/2006
4	FluoroquinolonesIBA 04/2017 - 04/2003
4	Moxifloxacin (Avelox)FDA Link 12/2011 - 01/2006
4	AgarIBA 05/2009 - 01/2005
4	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 09/2007 - 09/2002
3	Levofloxacin (Levaquin)FDA Link 08/2014 - 02/2008
3	Linezolid (Zyvox)FDA Link 08/2014 - 03/2005
3	AntralIBA 09/2003 - 02/2002
2	bezlotoxumabIBA 11/2021 - 01/2020
2	CB-183,315IBA 11/2020 - 04/2016
2	pexigananIBA 12/2017 - 01/2017
2	Daptomycin FDA Link 08/2014 - 04/2010
2	dalbavancinIBA 08/2014 - 08/2006
2	Ceftaroline FDA Link 07/2013 - 12/2012
2	FidaxomicinIBA 08/2012 - 11/2011
2	Pharmaceutical PreparationsIBA 11/2011 - 08/2011
2	Carbapenems (Carbapenem Antibiotics)IBA 08/2011 - 02/2008
2	Metronidazole (Metric)FDA LinkGeneric 07/2011 - 11/2002
2	garenoxacinIBA 05/2011 - 03/2002
2	Meropenem (Merrem)FDA LinkGeneric 04/2009 - 09/2002
2	Imipenem FDA Link 04/2009 - 02/2008
2	Doripenem FDA Link 04/2009 - 02/2008
2	telithromycin (Ketek)FDA Link 01/2007 - 06/2003
1	Monoclonal AntibodiesIBA 11/2021
1	actoxumabIBA 01/2020
1	eravacyclineIBA 08/2018
1	omadacyclineIBA 01/2018
1	Cephalosporins (Cephalosporin Antibiotics)IBA 04/2017
1	tedizolidIBA 02/2017
1	ridinilazoleIBA 08/2016
1	LipopeptidesIBA 04/2016
1	Rifampin (Rifampicin)FDA LinkGeneric 08/2014
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 08/2014
1	Doxycycline (Periostat)FDA LinkGeneric 08/2014
1	avibactamIBA 07/2013
1	ProdrugsIBA 12/2012
1	MBX-500IBA 09/2012
1	Explosive Agents (Explosives)IBA 08/2011
1	Oxygen (Dioxygen)IBA 02/2010
1	AerosolsIBA 02/2010
1	AntigensIBA 12/2009
1	VenomsIBA 06/2009
1	REP 3123IBA 05/2009
1	Cefotetan (Cefotan)FDA Link 04/2009
1	ceftobiproleIBA 11/2006
1	Tigecycline (Tygacil)FDA Link 10/2006
1	16S Ribosomal RNAIBA 08/2006
1	oritavancinIBA 02/2005
1	StreptograminsIBA 01/2005
1	linopristin drug combination flopristinIBA 01/2005
1	telavancin FDA Link 06/2004
1	delafloxacinIBA 09/2003
1	Erythromycin (Erycette)FDA LinkGeneric 06/2003
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 11/2002
1	Ticarcillin (Tarcil)FDA Link 11/2002
1	Clindamycin (Cleocin)FDA LinkGeneric 11/2002
1	Ciprofloxacin (Cipro)FDA LinkGeneric 11/2002
1	Chloramphenicol (Chloromycetin)FDA Link 11/2002
1	Cefoxitin (Cefoxitin Sodium)FDA LinkGeneric 11/2002
1	sultamicillin (ampicillin-sulbactam)FDA LinkGeneric 11/2002
1	Clavulanic Acid (Potassium Clavulanate)FDA LinkGeneric 11/2002
1	Amoxicillin-Potassium Clavulanate Combination (Co-amoxiclav)FDA Link 11/2002
1	fropenem (faropenem)IBA 09/2002
1	beta-LactamsIBA 09/2002
1	cellulose sulfateIBA 08/2002
1	polystyrene sulfonic acid (sodium polystyrene sulfonate)FDA LinkGeneric 08/2002

Therapy/Procedure

8	Therapeutics 01/2020 - 11/2005
3	Punctures 09/2003 - 02/2002
2	Debridement 08/2011 - 09/2007
1	Aftercare (After-Treatment) 08/2012
1	Length of Stay 12/2009
1	Curettage 09/2007